Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Thiosulfate for Coronary Calcification in Hemodialysis
NCT00720772Phase 2Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Jul 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sodium thiosulfate in Coronary artery calcification (CAC) (2 arms), sponsored by Ramathibodi Hospital. Primary endpoint: Coronary Calcification Score at 6 months. Started Jul 2008; status: completed.
02
Drugs
sodium thiosulfate
03
Conditions
Coronary artery calcification (CAC)
Beyond the preview
Go deeper on NCT00720772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00720772.